Edesa Biotech Q3 EPS $(0.60) Misses $(0.58) Estimate

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.58) by 3.45 percent. This is a 140 percent decrease over losses of $(0.25) per share from the same period last year.